ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628561 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628561; 2) Community: the network communities that were significantly associated with the response to NSC 628561; 3) Molecule: the relationships between components within communities and NSC 628561; 4) MDR: the compounds that were significantly associated with the NSC 628561.

NSC Compound Enrichment Correlation
NSC 728035 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di 0.0202245331784474 0.40148017
NSC 735408 Null 0.0202245331784474 0.4336601
NSC 736802 Null 0.0202245331784474 0.38684722
NSC 748712 Null 0.0202245331784474 0.33101683
NSC 758881 Orlistat (USAN) 0.0202245331784474 0.34108489
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0202245331784474 0.30019889
NSC 104942 EUPAROTIN 0.0202245331784479 0.45331358
NSC 144055 Picolinaldehyde, 5-hydroxy-, thiosemicarbazone, acetate (ester) (8CI) 0.0202245331784479 0.23203158
NSC 15309 2,5-Cyclohexadiene-1,4-dione, 2,5-dimethyl- (9CI) 0.0202245331784479 0.44827039
NSC 185057 Acetic acid, phenoxy-, 6-[[(aminothioxomethyl)hydrazono]methyl]-3-pyridinyl ester 0.0202245331784479 0.17843446
Total:91  Current:44    [First] [Prev] [Next] [Last]